Drug Type Small molecule drug |
Synonyms 3-hydroxypyridin-2-thione |
Target |
Action inhibitors |
Mechanism HDAC6 inhibitors(Histone deacetylase 6 inhibitors), HDAC8 inhibitors(Histone deacetylase 8 inhibitors), Epigenetic drug |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC5H5NOS |
InChIKeyMARYDOMJDFATPK-UHFFFAOYSA-N |
CAS Registry23003-22-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | United States | 18 Apr 2013 |